Iridex (IRIX) Free Cash Flow Growth (1y) (2012 - 2026)
Iridex (IRIX) Free Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 133.09% |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn | -36.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -36.37% |
| Jan 3, 2026 | 165.07% |
| Sep 27, 2025 | 54.96% |
| Jun 28, 2025 | 72.40% |
| Mar 29, 2025 | 36.22% |
| Dec 28, 2024 | -16.79% |
| Sep 28, 2024 | -49.85% |
| Jun 29, 2024 | -16.51% |
| Mar 30, 2024 | 42.79% |
| Dec 30, 2023 | 30.52% |
| Sep 30, 2023 | 30.70% |
| Jul 1, 2023 | 60.30% |
| Apr 1, 2023 | 11.99% |
| Dec 31, 2022 | -115.29% |
| Apr 2, 2022 | -127.59% |
| Apr 3, 2021 | 924.06% |
| Sep 26, 2020 | 118.36% |
| Jun 27, 2020 | -51.53% |
| Mar 28, 2020 | 61.93% |
| Dec 28, 2019 | 92.06% |